Trask JW. Vital statistics: a discussion of what they are and their uses in public health administration . Public Health Rep. 1915;;30(
(suppl 12)
):1-51.
Bowditch HI, Webster DL, Hoadley JC, et al. Letter from Massachusetts State Board of Health to physicians . Public Health Rep. 1915;;30(
(suppl 12)
):31.
Manual of Procedures for National Morbidity Reporting and Public Health Surveillance Activities . Atlanta, Ga: Centers for Disease Control; 1985;.
Fowler W. Laws and regulations relating to morbidity reporting . Public Health Rep. 1933;; 48(
(suppl 100)
):1-29.
Fowler W. The reportable diseases: diseases and conditions required to be reported in the several states . Public Health Rep. 1944;;59:317-340.
Benenson AS, ed. Control of Communicable Diseases in Man . 14th ed. Washington, DC: American Public Health Association; 1985;.
Centers for Disease Control. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination . MMWR. 1988;;37:197-200.
Freund E, Seligman PJ, Chorba TL, Safford SK, Drachman JG, Hull HF. Mandatory reporting of occupational diseases by clinicians . JAMA. 1989;;262:3041-3044.
Valleron A-J, Bouvet E, Garnerin P, et al. A computer network for the surveillance of communicable diseases: the French experiment . Am J Public Health . 1986;;76:1289-1292.
Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases . JAMA. 1983;;249:1181-1185.
Moro ML, McCormick A. Surveillance of communicable disease . In: Eylenbosch WJ, Noah ND, eds. Surveillance in Health and Disease . New York, NY: Oxford University Press Inc; 1988;:166-182.
Carter AO. Notifiable diseases in Canada . Can Med Assoc J. 1988;;139:645-648.
Centers for Disease Control. Guidelines for evaluating surveillance systems . MMWR . 1988;; 37(
(suppl S-5)
):1-18.
Sacks JJ. Utilization of case definitions and laboratory reporting in the surveillance of notifiable communicable diseases in the United States . Am J Public Health. 1985;;75:1420-1422.
Centers for Disease Control and Council of State and Territorial Epidemiologists. Case definitions for surveillance of notifiable diseases—administrative report . MMWR . In press.
Thacker SB, Berkelman RL. Public health surveillance in the United States . Epidemiol Rev. 1988;;10:164-190.
Lowry PW, Levine R, Stroup DF, Gunn RA, Wilder MH, Konigsberger C. Hepatitis A outbreak on a floating restaurant in Florida, 1986 . Am J Epidemiol. 1989;;129:155-164.
Centers for Disease Control. Hepatitis B associated with jet gun injection—California . MMWR. 1986;;35:373-376.
Reingold AL, Kane MA, Murphy BL, Checko P, Francis DP, Maynard JE. Transmission of hepatitis B by an oral surgeon . J Infect Dis. 1982;; 145:262-268.
Centers for Disease Control. Non-A, non-B hepatitis—Illinois . MMWR. 1989;;38:529-562.
Davis JP, Vergeront JM. The effect of publicity on the reporting of toxic-shock in Wisconsin . J Infect Dis. 1982;;145:449-457.
Todd JK, Wiesenthal AM, Ressman M, Caston SA, Hopkins RS. Toxic shock syndrome, II: estimated occurrence in Colorado as influenced by case ascertainment methods . Am J Epidemiol. 1985;; 122:857-867.
Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A, B, and non-A/non-B in the United States: CDC Sentinel County Hepatitis Study I . Am J Med. 1984;;76:69-74.
Eisenberg MS, Wiesner PJ. Reporting and treating gonorrhea: results of a statewide survey in Alaska . J Am Venereal Dis Assoc. 1976;;3:79-83.
Centers for Disease Control. National surveillance for Reye syndrome, 1981: update—Reye syndrome and salicylate usage . MMWR. 1982;;31:53-56,61.
Guillain-Barré Syndrome Surveillance Report, January 1978—March 1979 . Atlanta, Ga: Centers for Disease Control; 1980;.
Vogt RL, LaRue D, Klaucke DN, Jillson DA. Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont . Am J Public Health. 1983;;73:795-797.
Vogt RL, Clark SW, Kappel S. Evaluation of the state surveillance system using hospital discharge diagnoses, 1982-1983 . Am J Epidemiol. 1986;;123:197-198.
Reichelderfer PS, Kappus KD, Kendal AP. Economical laboratory support system for influenza virus surveillance . J Clin Microbiol. 1987;; 25:947-948.
Godes JR, Hall WN, Dean AG, Morse CD. Laboratory-based disease surveillance: a survey of state laboratory directors . Minn Med. 1982;;65:762-764.
Davis JP, Bohn MJ. The extent of underreporting of meningococcal disease in Wisconsin, 1980-1982 . Wis Med J. 1984;;83:11-14.
Choi K, Thacker SB. An evaluation of influenza mortality surveillance, 1962-79,I: time series forecasts of expected pneumonia and influenza deaths . Am J Epidemiol. 1981;;113:215-226.
Graitcer PL, Burton AH. The epidemiologic surveillance project: a computer-based system for disease surveillance . Am J Prev Med. 1987;;3:123-127.
Stroup DF, Williamson GD, Herndon JL, Karon JM. Detection of aberrations in the occurrence of notifiable diseases surveillance data . Stat Med. 1989;;8:323-329.
International Health Regulations (1969) . 3rd annotated ed. Geneva, Switzerland: World Health Organization; 1983;.
Konowitz PM, Petrossian GA, Rose DN. The underreporting of disease and physicians' knowledge of reporting requirements . Public Health Rep. 1984;;99:31-35.
Disease Surveillance: Who Reports? Burlington: Vermont Dept of Health; 1988;. Vermont Dept of Health Disease Control Bulletin.
Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis . Am J Epidemiol. 1987;;125:133-139.
Kimball AM, Thacker SB, Levy ME. Shigella surveillance in a large metropolitan area: assessment of a passive reporting system . Am J Public Health. 1980;;70:164-166.
Chalker RD, Blaser MJ. A review of human salmonellosis, III: magnitude of Salmonella infection in the United States . Rev Infect Dis. 1988;; 10:111-124.
Hepatitis A cluster: a need to report disease occurrence . Del Monthly Surveill Rep. 1989;;89:1-2.
Hinman AR, Eddins DL, Kirby CD, et al. Progress in measles elimination . JAMA. 1982;;247: 1592-1595.